Natural Nanoskin Advanced Cell Therapy (ACT) and Nanoskin ACT Soft towards the Definitive Solution for Acute and Chronic Wounds  

作　　者：Saqer Al Mualla Noura Salim Salman Nasreen Abdelatif Salma Al Ketbi Pierre Basmaji Mohamed Kanjou Mirvan Ahmad Saqer Al Mualla;Noura Salim Salman;Nasreen Abdelatif;Salma Al Ketbi;Pierre Basmaji;Mohamed Kanjou;Mirvan Ahmad(Qassimi Hospital, Sharjah, United Arab Emirates;Innovatec’s-Biotechnology Research and Development, Sã,o Carlos, Brazil;GEM International, Sharjah, United Arab Emirate)

机构地区：[1]Qassimi Hospital, Sharjah, United Arab Emirates [2]Innovatec’s-Biotechnology Research and Development, Sã,o Carlos, Brazil [3]GEM International, Sharjah, United Arab Emirate

出　　处：《Journal of Biomaterials and Nanobiotechnology》2023年第2期35-45,共11页生物材料与纳米技术（英文）

摘　　要：Natural Nanoskin Advance cell therapy (ACT) and Nanoskin ACT Soft have been established to be remarkably versatile biomaterials and can be used in a wide variety of applied scientific endeavors, especially for medical devices. In fact, the structure of Nanoskin materials can be adapted over length scales ranging from nano to macro by controlling the bio-fabrication process. The present paper describes Natural Nanoskin Advanced cell therapy (ACT) and Nanoskin ACT Soft production for wound care applications. ACT is produced from the bio-nanotechnology process. ACT is a highly hydrated pellicle with shaped fibers less than 2 nm wide. Nanoskin ACT Soft, like a paste, is designed to fill irregularities or recesses in the wound bed, and to absorb excess exudate from lesions by prolonging the used dressing's residence time and reducing the frequency of change.Natural Nanoskin Advance cell therapy (ACT) and Nanoskin ACT Soft have been established to be remarkably versatile biomaterials and can be used in a wide variety of applied scientific endeavors, especially for medical devices. In fact, the structure of Nanoskin materials can be adapted over length scales ranging from nano to macro by controlling the bio-fabrication process. The present paper describes Natural Nanoskin Advanced cell therapy (ACT) and Nanoskin ACT Soft production for wound care applications. ACT is produced from the bio-nanotechnology process. ACT is a highly hydrated pellicle with shaped fibers less than 2 nm wide. Nanoskin ACT Soft, like a paste, is designed to fill irregularities or recesses in the wound bed, and to absorb excess exudate from lesions by prolonging the used dressing's residence time and reducing the frequency of change.

关 键 词：Wound Care Diabetic Ulcer Natural Fibers 

分 类 号：R73[医药卫生—肿瘤]